Very early stage left ventricular endocardial dysfunction of patients with hypereosinophilic syndrome

Tetsushi Yamamoto1, Hidekazu Tanaka2, Chiyo Kurimoto1

  • 1Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan.

Insights

Early cardiac damage in hypereosinophilic syndrome (HES) is detectable. Global longitudinal strain (GLS) using 2D speckle-tracking identifies left ventricular endocardial dysfunction in HES patients before apparent heart involvement.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Imaging

Background:

  • Cardiac involvement in hypereosinophilic syndrome (HES) significantly increases morbidity and mortality.
  • Left ventricular (LV) endocardial damage is a key factor in HES cardiac complications.
  • Detecting very early-stage LV endocardial damage before overt cardiac symptoms is crucial for timely intervention.

Purpose of the Study:

  • To investigate subclinical left ventricular (LV) endocardial dysfunction in HES patients with normal conventional echocardiograms.
  • To evaluate the utility of global longitudinal strain (GLS) in identifying early-stage cardiac involvement in HES.

Main Methods:

  • Studied 32 HES patients and 31 matched healthy controls with normal echocardiograms.
  • Utilized 2D speckle-tracking to measure global radial, circumferential, and longitudinal strain (GRS, GCS, GLS).
  • Performed receiver operating characteristic (ROC) curve analysis to determine GLS predictive value for LV endocardial dysfunction.

Main Results:

  • While GRS and GCS were similar between groups, HES patients showed significantly lower GLS (16.2 ± 3.3% vs 19.3 ± 2.9%, p < 0.001).
  • GLS ≤17.0% was identified as the optimal predictor of LV endocardial dysfunction (AUC=0.781, sensitivity=66%, specificity=78%).
  • LV endocardial dysfunction was present in HES patients even without apparent cardiac involvement.

Conclusions:

  • Subclinical LV endocardial dysfunction precedes overt cardiac involvement in HES.
  • Two-dimensional speckle-tracking derived GLS is a valuable tool for detecting very early cardiac changes in HES patients.
  • Early detection of LV dysfunction can improve management strategies for HES patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
953
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
751
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
785
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
714
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K